The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemiaEnrico Maffini, Francesca Bonifazi, Margherita Ursi et al.|Frontiers in Oncology|2022Cited by 8
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patientsGianluca Storci, Francesca Bonifazi, Francesco Barbato et al.|Frontiers in Immunology|2023Cited by 7
Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcomeSerena De Matteis, Francesca Bonifazi, Laura Del Coco et al.|Haematologica|2024Cited by 3
Old age: the crown of life, our play's last act. Question and answers on older patients undergoing allogeneic hematopoietic cell transplantationEnrico Maffini, Francesca Bonifazi, Moreno Festuccia et al.|Current Opinion in Hematology|2022Cited by 1
Azacitidine maintenance after allogeneic hematopoietic stem cell transplantation in high-risk AML: a single-center retrospective studyFederica Ardizzoia, Francesca Bonifazi, F Iannotta et al.|Zenodo (CERN European Organization for Nuclear Research)|2026Cited by 0